Type 1 (insulin-dependent) diabetes mellitus, like other organ specific autoimmune diseases, results from a disorder of immunoregulation. T cells specific for pancreatic islet 6 cell constituents (autoantigens) exist normally but are restrained by regulatory mechanisms (self-tolerant state). When regulation fails, t cell-specific autoreactive T cells become activated and expand clonally. Current evidence indicates that islet t cell-specific autoreactive T cells belong to a T helper 1 (Thl) subset, and these Thl cells and their characteristic cytokine products, IFN and IL-2, are believed to cause islet inflammation (insulitis) and tg cell destruction. Immune-mediated destruction of fg cells precedes hyperglycemia and clinical symptoms by many years because these become apparent only when most of the insulin-secreting fg cells have been destroyed. Therefore, several approaches are being tested or are under consideration for clinical trials to prevent or arrest complete autoimmune destruction of islet g cells and insulin-dependent diabetes. Approaches that attempt to correct underlying immunoregulatory defects in autoimmune diabetes include interventions aimed at i) deleting t cell autoreactive Thl cells and cytokines and/or ii) increasing regulatory Th2 cells and/or Th3 cells and their cytokine products and TGFfI). (Fig. 2) .
The functional significance of Thl and Th2 cell subsets is that their distinct patterns of cytokine secretion lead to strikingly different T cell actions. 127, 28, (Fig. 2) .
According to the scheme depicted in Figure 2 (Fig. 3) 123, 1241 and IL-2 [125, 126] production. This supports the concept that Thl cell activation can lead to self-deletion via apoptosis and, consequently, specific T cell tolerance to the stimulating antigen. [15] Semp, P., Richard, M. E, Bach, J. E and Boitard, C. (1994) .
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